Application of region-specific immunoassay for human chromogranin A: Substantial clue for detection and measurement of chromogranin A in human plasma

Regulatory Peptides

Volumn 80, Issue 1-2, 1999, Pages 83-90

  Yanaihara, Hitoshi ^a   Hata, Makoto ^b   Nishikawa, Yasuko ^c   Hoshino, Minoru ^c   Yanaihara, Noboru ^d   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d Yanaihara Institute Inc   (Japan)

Author keywords

Chromogranin A; Gel chromatography; HPLC; Pheochromocytoma; Radioimmunoassay; Synthetic peptide

Indexed keywords

CHROMOGRANIN A; PROTEIN ANTIBODY; SYNTHETIC PEPTIDE;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOREACTIVITY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; RADIOIMMUNOASSAY;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY FORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; CHROMOGRANIN A; CHROMOGRANINS; DOPAMINE; EPINEPHRINE; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NOREPINEPHRINE; PHEOCHROMOCYTOMA; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0033058629     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00015-4     Document Type: Article

References (44)

1. Konecki DS, Benedum UM, Gerdes HH, Huttner WB. The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987;262:17026-30.
2. Sage HJ, Smith WJ, Kirshner N. Mechanism of secretion from the adrenal medulla. I. A microquantitative immunologic assay for bovine adrenal catecholamine storage vesicle protein and its application to studies of the secretory process. Mol Pharmacol 1967;3:81-9.
3. O'Connor DT, Frigon RP, Sokoloff RL. Human chromogranin A: purification and characterization from catecholamine storage vesicles of human pheochromocytoma. Hypertension 1984;6:2-12.
4. O'Connor DT, Frigon RP. Chromogranin A, the major catecholamine storage vesicle soluble protein: multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. J Biol Chem 1984;259:3237-47.
5. O'Connor DT, Bernstein KN. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 1984;311:764-70.
6. O'Connor DT, Deftos LJ. How sensitive and specific is measurement of plasma chromogranin A for the diagnosis of neuroendocrine neoplasia?. Ann NY Acad Sci 1987;493:379-86.
7. O'Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986;314:1145-51.
8. O'Connor DT, Pandlan MR, Carlton E, Cervenka JH, Hsiao RJ. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem 1989;35:1631-7.
9. O'Connor DT, Takiyyuddin MA, Cervenka JH, Parmer RJ, Barbosa JA, Chang YM, Hsiao RJ. Circulating chromogranin A as a diagnostic tool in clinical chemistry. Acta Histochem Suppl 1990;38:27-33.
10. Eriksson B, Arnberg H, Öberg K, Hellman U, Lundqvist G, Wernstedt C, Wilander E. Chromogranins - new sensitive markers for neuroendocrine tumors. Acta Oncol 1989;28:325-9.
11. Hsiao RJ, Parmer RJ, Takiyyuddin MA, O'Connor DT. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine 1991;70:33-45.
12. Yanaihara C, Kadowaki M, Hoshino M, Kishida S, Suzuki T, Yanaihara N. Production of region-specific antisera to human prorenin and renin using synthetic peptides. Biomed Res 1987;8:95-101.
13. Yanaihara N, Yanaihara C, Hoshino M, Mochizuki T, Iguchi K. Immunochemical and biochemical properties of purposely designed synthetic peptides. Ann NY Acad Sci 1988;527:29-43.
14. Toyoshige M, Yanaihara C, Hoshino M, Kaneko T, Yanaihara N. Insulin receptor in human hepatoma PLC/PRF/5 cell and its immunochemical characterization with anti-synthetic peptide antibodies. Biomed Res 1989;10:139-47.
15. Kurokawa N, Hirotani Y, Arakawa Y, Iguchi K, Urabe N, Yanaihara N, Abe K, Yanaihara C. Increased production of c-myc and c-fos related proteins during late stage of regenerative process in rat liver after partial hepatectomy. Biomed Res 1990;11:165-72.
16. Kurokawa N, Hirotani Y, Takashima N, Sawada M, Iguchi K, Yanaihara N, Arakawa Y, Yanaihara C. RB gene product levels measured by a specific radioimmunoassay decrease in regenerating rat liver after partial hepatectomy. Biomed Res 1995;16:69-72.
17. Kataoka K, Kurokawa N, Sawada M, Iguchi K, Yanaihara N, Takahara S, Okuyama A, Yanaihara C. Region-specific radio-immunoassay systems for human prorenin and renin with use of synthetic peptide. Biomed Res 1995;16:363-70.
18. Nagasawa S, Nishikawa Y, Ohshima K, Iguchi K, Mochizuki T, Greeley GH, Yanaihara N. Distribution of chromogranin A-like peptides in the rat. Biomed Res 1995;16:83-90.
19. Tatemoto K, Efendic S, Mutt V, Makk G, Feistner GJ, Barchas JD. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986;324:476-8.
20. Deftos LJ, Hogue-Angeletti R, Chalberg C, Tu S. A chromogranin A-derived peptide differentially regulates the secretion of calcitonin gene products. J Bone Miner Res 1990;5:989-91.
21. Drees BM, Rouse J, Johnson J, Hamilton JW. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 1991;129:3381-7.
22. Galindo E, Rill A, Bader MF, Aunis D. Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion. Proc Natl Acad Sci USA 1991;88:1426-30.
23. Aardal S, Helle KB. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept 1992;41:9-18.
24. Fasciotto BH, Trauss CA, Greeley GH, Cohn DV. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 1993;133:461-6.
25. Watkinson A, Jönsson A-C, Davison M, Young J, Lee CM, Moore S, Dockray GJ. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem J 1991;276:471-9.
26. Watkinson A, Rogers M, Dockray GJ. Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum. Biochem J 1993;295:649-54.
27. Simon J-P, Bader M-F, Aunis D. Proteolytic processing of chromogranin A in cultured chromaffin cells. Biochim Biophys Acta 1989;1051:123-30.
28. Metz-Boutique M-H, Garcia-Sablone P, Hogue-Angeletti R, Aunis D. Intracellular and extracellular processing of chromogranin. A determination of cleavage sites. Eur J Biochem 1993;217:247-57.
29. Weiler R, Steiner H-J, Fischer-Colbrie R, Schmid KW, Winkler H. Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney. Histochemistry 1991;96:395-9.
30. Woussen-Colle M-C, Lingier P, Vertongen P, Vandermeers-Piret M-C, Vandermeers A, Robberecht P. Chromogranin A (210-301) is the major form of pancreastatin-like material in human gut extracts and endocrine tumors. Peptides 1994;15:869-74.
31. Stridsberg M, Öberg K, Li Q, Engström U, Lundqvist G. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours. J Endocrinol 1995;144:49-59.
32. Tateishi K, Kitayama N, Matsuoka Y, Funakoshi A. Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor. Life Sci 1995;57:889-95.
33. Corti A, Longhi R, Gasparri A, Chen F, Pelagi M, Siccardi AG. Antigenic regions of human chromogranin A and their topographic relationships with structural/functional domains. Eur J Biochem 1996;235:275-80.
34. Stridsberg M, Hellman U, Wilander E, Lundqvist G, Hellsing K, Öberg K. Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 1993;139:329-37.
35. Schmidt WE, Siegel EG, Kratzin H, Creutzfeldt W Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci USA 1988;85:8231-5.
36. Hutton JC, Nielsen E, Kastern W The molecular cloning of the chromogranin A-like precursor of β-granin and pancreastatin from the endocrine pancreas. FEBS Lett 1988;236:269-74.
37. Barbosa JA, Gill BM, Takiyyuddin MA, O'Connor DT. Chromogranin A: Posttranslational modifications in secretory granules. Endocrinology 1991;128:174-90.
38. Corti A, Gasparri A, Chen F-X, Pelagi M, Brandazza A, Sidoli A, Siccardi AG. Characterisation of circulating chromogranin A in human cancer patients. Br J Cancer 1996;73:924-32.
39. Syversen U, Jacobsen MB, O'connor K, Rønning K, Waldum HL. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides 1994;26:201-6.
40. Boomsma F, Bhaggoe UM, Manin't Veld AJ, Schalekamp MADH. Sensitivity and specificity of a new ELISA method for determination of chromogranin A in the diagnosis of pheochromocytoma and neuroblastoma. Clin Chim Acta 1995;239:57-63.
41. Hsiao RJ, Neumann HP, Parmer RJ, Barbosa JA, O'Connor DT. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. Am J Med 1990;88:607-13.
42. Cryer PE, Wortsman J, Shah SD, Nowak RM, Deftos LJ. Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol 1991;260:E243-6.
43. Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 1986;110:1154-62.
44. Simon JP, Aunis D. Biochemistry of the chromogranin A protein family. Biochem J 1989;262:1-13.